戻る Agenda
Study Startup Symposium
Session Chair(s)
Mary Jo Lamberti, PHD, MA
Director of Sponsored Research, Research Associate Professor
Tufts Center for the Study of Drug Development, United States
Benchmarking the Study Startup Process
Learning Objective : Define key activities identified by companies that comprise site initiation and show specific cycle time metrics for study startup; Illustrate the importance of efficient study start up and open communication to overall timelines; Identify key challenges to running efficient investigator meetings and discuss solutions to these challenges.
Speaker(s)
Benchmarking the Study Startup Process
Mary Jo Lamberti, PHD, MA
Tufts Center for the Study of Drug Development, United States
Director of Sponsored Research, Research Associate Professor
Moving Investigator Meetings into the 21st Century
Leslie (Mi Ok) Chong, MA
Genentech, A Member of the Roche Group, United States
Senior Clinical Program Leader
Insights to Accelerate Your Clinical Trial: How Proactive Planning in Study Startup Drives Efficiencies in Drug Development
Shyla VanReenen
Synteract, Inc., United States
Senior Manager, Clinical Operations